The number of brain metastases predicts the survival of non-small cell lung cancer patients with EGFR mutation status.

Jun ShaoJingwei LiLujia SongQiuyao HeYuxuan WuLinhui LiDan LiuChengdi Wang Wei-Min Li

Published in: Cancer reports (Hoboken, N.J.) (2021)

The number of brain metastases was a prognostic factor for lung cancer patients either with EGFR mutations or with wild-type EGFR, with larger number indicating more unfavorble clinical outcomes. Patients with EGFR mutations had a better survival.

Keyphrases

small cell lung cancer
brain metastases
prognostic factors
epidermal growth factor receptor
wild type
tyrosine kinase
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
free survival
patient reported outcomes
patient reported